RHINE™ Cervical Disc Study

  • Research type

    Research Study

  • Full title

    RHINE™ Cervical Disc Prospective Observational Clinical Study

  • IRAS ID

    225195

  • Contact name

    Gladys Annan

  • Contact email

    gannan@K2M.com

  • Sponsor organisation

    K2M, Inc

  • Clinicaltrials.gov Identifier

    NCT02403453

  • Duration of Study in the UK

    5 years, 0 months, 1 days

  • Research summary

    The purpose of the RHINE™ Cervical Disc Prospective Observational Clinical Study Protocol is to collect data on patient’s clinical and radiographic outcomes from neck (cervical) spinal surgery utilizing RHINE™ Cervical Disc (“RHINE Disc”). Eligible patients include those aged 18 and over, whose neck spine condition requires treatment. That treatment includes the removal of the disc between the bones making up the spine and replacement of the disc with an artificial disc to aid in the steadying and re-positioning of the cervical spine. The RHINE Disc is made of medical grade titanium alloy and a compressible core designed to provide shock absorption and controlled motion very close to the natural disc.
    Patients will complete standard health related questionnaires and X-rays.
    A total of 166 patients are being recruited for this study from approximately 10 study sites in 6-8 European countries.
    Patients will be required to return for Follow up visits at the following time points; between 6-12 weeks, 6 months, 12 months, 24 months and 60 months post-procedure.
    There are no experimental products, procedures, or tests involved in this study; only data on how the patient is doing before and after surgery will be collected.

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    18/LO/0228

  • Date of REC Opinion

    3 Apr 2018

  • REC opinion

    Further Information Favourable Opinion